Identification of a selective BRD4 PROTAC with potent antiproliferative effects in AR-positive prostate cancer based on a dual BET/PLK1 inhibitor
- Resource Type
- Article
- Source
- In
European Journal of Medicinal Chemistry 5 January 2022 227 - Subject
- Language
- ISSN
- 0223-5234